{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:59:39Z","timestamp":1791176379341,"version":"4.1.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T00:00:00Z","timestamp":1338854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/nrgastro.2012.111","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T13:31:18Z","timestamp":1338903078000},"page":"445-453","source":"Crossref","is-referenced-by-count":127,"title":["Familial pancreatic cancer\u2014current knowledge"],"prefix":"10.1038","volume":"9","author":[{"given":"Detlef K.","family":"Bartsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,5]]},"reference":[{"key":"BFnrgastro2012111_CR1","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/1097-0142(19870501)59:9<1661::AID-CNCR2820590923>3.0.CO;2-H","volume":"59","author":"D Ehrenthal","year":"1987","unstructured":"Ehrenthal, D., Haeger, L., Griffin, T. & Compton, C. Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature. Cancer 59, 1661\u20131664 (1987).","journal-title":"Cancer"},{"key":"BFnrgastro2012111_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0016-5085(19)33156-7","volume":"65","author":"RP MacDermott","year":"1973","unstructured":"MacDermott, R. P. & Kramer, P. Adenocarcinoma of the pancreas in four siblings. Gastroenterology 65, 137\u2013139 (1973).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2012111_CR3","first-page":"1911","volume":"23","author":"RR Reimer","year":"1977","unstructured":"Reimer, R. R., Fraumeni, J. F. Jr, Ozols, R. F. & Bender, R. Pancreatic cancer in father and son. Lancet 23, 1911 (1977).","journal-title":"Lancet"},{"key":"BFnrgastro2012111_CR4","first-page":"54","volume":"85","author":"HT Lynch","year":"1990","unstructured":"Lynch, H. T. et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am. J. Gastroenterol. 85, 54\u201369 (1990).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2012111_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1055-3207(18)30282-5","volume":"7","author":"RH Hruban","year":"1998","unstructured":"Hruban, R. H., Petersen, G. M., Ha, P. K. & Kern, S. E. Genetics of pancreatic cancer. From genes to families. Surg. Oncol. Clin. N. Am. 7, 1\u201323 (1998).","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"BFnrgastro2012111_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0025-7125(05)70241-8","volume":"84","author":"SE Applebaum","year":"2000","unstructured":"Applebaum, S. E., Kant, J. A., Whitcomb, D. C. & Ellis, I. H. Genetic testing. Counselling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med. Clin. North Am. 84, 575\u2013588 (2000).","journal-title":"Med. Clin. North Am."},{"key":"BFnrgastro2012111_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1159\/000055853","volume":"1","author":"DK Bartsch","year":"2001","unstructured":"Bartsch, D. K. et al. Update of familial pancreatic cancer in Germany. Pancreatology 1, 510\u2013516 (2001).","journal-title":"Pancreatology"},{"key":"BFnrgastro2012111_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.dld.2010.04.016","volume":"42","author":"M Del Chiaro","year":"2010","unstructured":"Del Chiaro, M. et al. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig. Liver Dis. 42, 597\u2013605 (2010).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2012111_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.yasu.2010.05.011","volume":"44","author":"RH Hruban","year":"2010","unstructured":"Hruban, R. H., Canto, M. I., Goggins, M., Schulik, R. & Klein, A. P. Update on familial pancreatic cancer. Adv. Surg. 44, 293\u2013311 (2010).","journal-title":"Adv. Surg."},{"key":"BFnrgastro2012111_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000108962","volume":"7","author":"M Del Chiaro","year":"2007","unstructured":"Del Chiaro, M. et al. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology 7, 459\u2013469 (2007).","journal-title":"Pancreatology"},{"key":"BFnrgastro2012111_CR11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ijc.20210","volume":"110","author":"DK Bartsch","year":"2004","unstructured":"Bartsch, D. K. et al. Prevalence of familial pancreatic cancer in Germany. Int. J. Cancer 110, 902\u2013906 (2004).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2012111_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ijc.10863","volume":"10","author":"K Hemminki","year":"2003","unstructured":"Hemminki, K. & Li, X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int. J. Cancer 10, 525\u2013530 (2003).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2012111_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10689-008-9214-8","volume":"8","author":"J Permuth-Wey","year":"2009","unstructured":"Permuth-Wey, J. & Egan, K. M. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and metaanalysis. Fam. Cancer 8, 109\u2013117 (2009).","journal-title":"Fam. Cancer"},{"key":"BFnrgastro2012111_CR14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/bjs.4127","volume":"90","author":"DK Bartsch","year":"2003","unstructured":"Bartsch, D. K. Familial pancreatic cancer. Br. J. Surg. 90, 386\u2013387 (2003).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro2012111_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/ng0198-38","volume":"18","author":"DE Jenne","year":"1998","unstructured":"Jenne, D. E. et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 18, 38\u201343 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2012111_CR16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJM198706113162404","volume":"316","author":"FM Giardiello","year":"1987","unstructured":"Giardiello, F. M. et al. Increased risk of cancer in the Peutz\u2013Jeghers syndrome. N. Engl. J. Med. 316, 1511\u20131514 (1987).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2012111_CR17","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJM199510123331504","volume":"333","author":"AM Goldstein","year":"1995","unstructured":"Goldstein, A. M. et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N. Engl. J. Med. 333, 970\u2013974 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2012111_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJM199510123331505","volume":"333","author":"AJ Whelan","year":"1995","unstructured":"Whelan, A. J., Bartsch, D. K. & Goodfellow, P. J. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N. Engl. J. Med. 333, 975\u2013977 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2012111_CR19","first-page":"9484","volume":"1","author":"HT Lynch","year":"2002","unstructured":"Lynch, H. T. et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 1, 9484\u20139496 (2002).","journal-title":"Cancer"},{"key":"BFnrgastro2012111_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1399-0004.2009.01352.x","volume":"77","author":"DK Bartsch","year":"2010","unstructured":"Bartsch, D. K. et al. Clinical and genetic analysis of 18 pancreatic carcinoma\/melanoma-prone families. Clin. Genet. 77, 333\u2013341 (2010).","journal-title":"Clin. Genet."},{"key":"BFnrgastro2012111_CR21","first-page":"87809","volume":"15","author":"HF Vasen","year":"2000","unstructured":"Vasen, H. F. et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int. J. Cancer 15, 87809\u201387811 (2000).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2012111_CR22","doi-asserted-by":"crossref","unstructured":"[No authors listed] Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J. Natl Cancer Inst. 91, 1310\u20131316 (1999).","DOI":"10.1093\/jnci\/91.15.1310"},{"key":"BFnrgastro2012111_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jmg.2004.028829","volume":"42","author":"CJ van Asperen","year":"2005","unstructured":"van Asperen, C. J. et al. Cancer risk in BRCA2 families: estimates for sites other than breast and ovary. J. Med. Genet. 42, 711\u2013719 (2005).","journal-title":"J. Med. Genet."},{"key":"BFnrgastro2012111_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng0597-17","volume":"16","author":"H Ozcelik","year":"1997","unstructured":"Ozcelik, H. et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat. Genet. 16, 17\u201318 (1997).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2012111_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ng1096-188","volume":"14","author":"C Oddoux","year":"1996","unstructured":"Oddoux, C. et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat. Genet. 14, 188\u2013190 (1996).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2012111_CR26","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson, D. & Easton, D. F. Cancer incidence in BRCA1 mutation carriers. Breast Cancer Linkage Consortium. J. Natl Cancer Inst. 94, 1358\u20131365 (2002).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2012111_CR27","doi-asserted-by":"publisher","unstructured":"Moran, A. et al. Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam. Cancer http:\/\/dx.doi.org\/10.1007\/s10689-011-9506-2 .","DOI":"10.1007\/s10689-011-9506-2"},{"key":"BFnrgastro2012111_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/bjc.1985.187","volume":"52","author":"HT Lynch","year":"1985","unstructured":"Lynch, H. T., Voorhees, G. J., Lanspa, S. J., McGreevy, P. S. & Lynch, J. F. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br. J. Cancer 52, 271\u2013273 (1985).","journal-title":"Br. J. Cancer"},{"key":"BFnrgastro2012111_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","volume":"81","author":"M Aarnio","year":"1999","unstructured":"Aarnio, M. et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int. J. Cancer 81, 214\u2013218 (1999).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2012111_CR30","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos, F. et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302, 1790\u20131795 (2009).","journal-title":"JAMA"},{"key":"BFnrgastro2012111_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/gut.51.3.446","volume":"51","author":"F Maire","year":"2002","unstructured":"Maire, F. et al. Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut 51, 446\u2013449 (2002).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR32","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.34.10.1394","volume":"34","author":"FM Giardello","year":"1993","unstructured":"Giardello, F. M. et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34, 1394\u20131396 (1993).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng1096-141","volume":"14","author":"DC Whitcomb","year":"1996","unstructured":"Whitcomb, D. C. et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 14, 141\u2013145 (1996).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2012111_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/76088","volume":"25","author":"H Witt","year":"2000","unstructured":"Witt, H. et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat. Genet. 25, 213\u2013216 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2012111_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0025-7125(05)70240-6","volume":"84","author":"AB Lowenfels","year":"2000","unstructured":"Lowenfels, A. B., Maisonneuve, P. & Whitcomb, D. C. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med. Clin. North Am. 84, 565\u2013573 (2000).","journal-title":"Med. Clin. North Am."},{"key":"BFnrgastro2012111_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jama.286.2.169","volume":"286","author":"AB Lowenfels","year":"2001","unstructured":"Lowenfels, A. B., Maisonneuve, P., Whitcomb, D. C., Lerch, M. M. & DiMagno, E. P. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286, 169\u2013170 (2001).","journal-title":"JAMA"},{"key":"BFnrgastro2012111_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1572-0241.2007.01597.x","volume":"103","author":"V Rebours","year":"2008","unstructured":"Rebours, V. et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am. J. Gastroneterol. 103, 111\u2013119 (2008).","journal-title":"Am. J. Gastroneterol."},{"key":"BFnrgastro2012111_CR38","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/gut.2007.125278","volume":"56","author":"P Maisonneuve","year":"2007","unstructured":"Maisonneuve, P., Marshall, B. C. & Lowenfels, A. B. Risk of pancreatic cancer in patients with cystic fibrosis. Gut 56, 1327\u20131328 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR39","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1136\/gut.2006.108456","volume":"56","author":"RE Brand","year":"2007","unstructured":"Brand, R. E. et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56, 1460\u20131469 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000055849","volume":"1","author":"HT Lynch","year":"2001","unstructured":"Lynch, H. T., Brand, R. E., Deters, C. A., Shaw, T. G. & Lynch, J. F. Hereditary pancreatic cancer. Pancreatology 1, 466\u2013471 (2001).","journal-title":"Pancreatology"},{"key":"BFnrgastro2012111_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/A:1008345021197","volume":"10","author":"RH Hruban","year":"1999","unstructured":"Hruban, R. H. et al. Familial pancreatic cancer. Ann. Oncol. 10, 69\u201373 (1999).","journal-title":"Ann. Oncol."},{"key":"BFnrgastro2012111_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10689-010-9414-x","volume":"10","author":"R Schneider","year":"2011","unstructured":"Schneider, R. et al. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam. Cancer 10, 323\u2013330 (2011).","journal-title":"Fam. Cancer"},{"key":"BFnrgastro2012111_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/gut.2006.098814","volume":"55","author":"W Greenhalf","year":"2006","unstructured":"Greenhalf, W. et al. Anticipation in familial pancreatic cancer. Gut 55, 252\u2013258 (2006).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR44","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/S0016-5085(03)00272-5","volume":"124","author":"SJ Rulyak","year":"2003","unstructured":"Rulyak, S. J., Lowenfels, A. B., Maisonneuve, P. & Brentnall, T. A. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 124, 1292\u20131299 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2012111_CR45","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1158\/1055-9965.EPI-09-0557","volume":"18","author":"L Wang","year":"2009","unstructured":"Wang, L. et al. Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 18, 2829\u20132834 (2009).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro2012111_CR46","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","volume":"64","author":"AP Klein","year":"2004","unstructured":"Klein, A. P. et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 64, 2634\u20132638 (2004).","journal-title":"Cancer Res."},{"key":"BFnrgastro2012111_CR47","first-page":"738","volume":"7","author":"AC Tersmette","year":"2001","unstructured":"Tersmette, A. C. et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin. Cancer Res. 7, 738\u2013744 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2012111_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jnci\/djp466","volume":"102","author":"KA Brune","year":"2010","unstructured":"Brune, K. A. et al. Importance of age of onset in pancreatic cancer kindreds. J. Natl Cancer Inst. 102, 119\u2013126 (2010).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2012111_CR49","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/path.3017","volume":"226","author":"M Aichler","year":"2012","unstructured":"Aichler, M. et al. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J. Pathol. 226, 723\u2013734 (2012).","journal-title":"J. Pathol."},{"key":"BFnrgastro2012111_CR50","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"476","author":"S Yachida","year":"2010","unstructured":"Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 476, 1114\u20131147 (2010).","journal-title":"Nature"},{"key":"BFnrgastro2012111_CR51","first-page":"1067","volume":"30","author":"K Brune","year":"2006","unstructured":"Brune, K. et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am. J. Surg. Pathol. 30, 1067\u20131076 (2006).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrgastro2012111_CR52","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1158\/1078-0432.CCR-09-0004","volume":"15","author":"C Shi","year":"2009","unstructured":"Shi, C. et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin. Cancer Res. 15, 7737\u20137743 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2012111_CR53","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gut.2010.214163","volume":"59","author":"P Langer","year":"2010","unstructured":"Langer, P., Gress, T. M. & Bartsch, D. K. Pancretic cancer screening in individuals at risk- too early for a general implementation on a health care basis. Gut 59, 1006\u20131007 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/SLA.0b013e3181c5ddc3","volume":"251","author":"T Ingkakul","year":"2010","unstructured":"Ingkakul, T. et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal. Ann. Surg. 251, 70\u201375 (2010).","journal-title":"Ann. Surg."},{"key":"BFnrgastro2012111_CR55","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/gut.2007.145631","volume":"57","author":"H Uehara","year":"2008","unstructured":"Uehara, H. et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 57, 1561\u20131565 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/gepi.1102","volume":"23","author":"AP Klein","year":"2002","unstructured":"Klein, A. P. et al. Evidence for a major gene influencing risk of pancreatic cancer. Genet. Epidemiol. 23, 133\u2013137 (2002).","journal-title":"Genet. Epidemiol."},{"key":"BFnrgastro2012111_CR57","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/339692","volume":"70","author":"MA Eberle","year":"2002","unstructured":"Eberle, M. A. et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32\u201334. Am. J. Hum. Genet. 70, 1044\u20131048 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrgastro2012111_CR58","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1371\/journal.pmed.0030516","volume":"3","author":"KL Pogue-Geile","year":"2006","unstructured":"Pogue-Geile, K. L. et al. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 3, e516 (2006).","journal-title":"PLoS Med."},{"key":"BFnrgastro2012111_CR59","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1158\/1055-9965.EPI-06-0376","volume":"15","author":"J Earl","year":"2006","unstructured":"Earl, J. et al. Evaluation of the 4q32\u201334 locus in European familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 15, 1948\u20131955 (2006).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro2012111_CR60","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.pmed.0040164","volume":"4","author":"E Slater","year":"2007","unstructured":"Slater, E. et al. Palladin mutation causes familial pancreatic cancer: absence in European families. PLoS Med. 4, e164 (2007).","journal-title":"PLoS Med."},{"key":"BFnrgastro2012111_CR61","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1158\/1055-9965.EPI-09-0056","volume":"18","author":"AP Klein","year":"2009","unstructured":"Klein, A. P. et al. Absence of deleterious palladin mutations in patients with familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 18, 1328\u20131330 (2009).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro2012111_CR62","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/00000658-200212000-00005","volume":"236","author":"DK Bartsch","year":"2002","unstructured":"Bartsch, D. K. et al. CDKN2A germline mutations in familial pancreatic cancer. Ann. Surg. 236, 730\u2013737 (2002).","journal-title":"Ann. Surg."},{"key":"BFnrgastro2012111_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10689-010-9329-6","volume":"9","author":"E Slater","year":"2010","unstructured":"Slater, E. et al. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families. Fam. Cancer 9, 335\u2013343 (2010).","journal-title":"Fam. Cancer"},{"key":"BFnrgastro2012111_CR64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jnci\/95.3.214","volume":"95","author":"SA Hahn","year":"2003","unstructured":"Hahn, S. A. et al. BRCA2 germline mutations in familial pancreatic carcinoma. J. Natl Cancer Inst. 95, 214\u2013221 (2003).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2012111_CR65","first-page":"3789","volume":"62","author":"KM Murphy","year":"2002","unstructured":"Murphy, K. M. et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 62, 3789\u20133793 (2002).","journal-title":"Cancer Res."},{"key":"BFnrgastro2012111_CR66","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","volume":"16","author":"FJ Couch","year":"2007","unstructured":"Couch, F. J. et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 16, 342\u2013346 (2007).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro2012111_CR67","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ccr.2010.10.015","volume":"18","author":"F Skoulidis","year":"2010","unstructured":"Skoulidis, F. et al. Germline Brca2 heterozygosity promotes KrasG12D-driven carcinogenesis in a murine model of familial pancreatic cancer. Cancer Cell 18, 499\u2013509 (2010).","journal-title":"Cancer Cell"},{"key":"BFnrgastro2012111_CR68","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1053\/j.gastro.2010.12.039","volume":"140","author":"M Rowley","year":"2011","unstructured":"Rowley, M. et al. Inactivation of BRCA2 promotes Trp53-asociated but inhibits KrasG12D-dependent pancreatic cancer development in mice. Gastroenterology 140, 1303\u20131313 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2012111_CR69","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4161\/cbt.11.11.15534","volume":"11","author":"G Feldmann","year":"2011","unstructured":"Feldmann, G. et al. Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer. Cancer Biol. Ther. 11, 959\u2013968 (2011).","journal-title":"Cancer Biol. Ther."},{"key":"BFnrgastro2012111_CR70","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant, H. E. et al. Specific killing of BRCA2-deficient tumors with inhibitors of poly (ADP-ribose) polymerase. Nature 434, 913\u2013917 (2005).","journal-title":"Nature"},{"key":"BFnrgastro2012111_CR71","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/CAD.0b013e32832b511e","volume":"20","author":"E James","year":"2009","unstructured":"James, E., Waldron-Lynch, M. G. & Saif, M. W. Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature. Anticancer Drugs 20, 634\u2013638 (2009).","journal-title":"Anticancer Drugs"},{"key":"BFnrgastro2012111_CR72","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.1171202","volume":"324","author":"S Jones","year":"2009","unstructured":"Jones, S. et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324, 217\u2013220 (2009).","journal-title":"Science"},{"key":"BFnrgastro2012111_CR73","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1399-0004.2010.01425.x","volume":"78","author":"EP Slater","year":"2010","unstructured":"Slater, E. P. et al. PALB2 mutations in European familial pancreatic cancer families. Clin. Genet. 78, 490\u2013494 (2010).","journal-title":"Clin. Genet."},{"key":"BFnrgastro2012111_CR74","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ejhg.2011.226","volume":"20","author":"F Harinck","year":"2012","unstructured":"Harinck, F. et al. Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated. Eur. J. Hum. Genet. 20, 577\u2013579 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrgastro2012111_CR75","first-page":"2585","volume":"63","author":"MS van der Heijden","year":"2003","unstructured":"van der Heijden, M. S., Yeo, C. J., Hruban, R. H. & Kern, S. E. Fanconi anemia gene mutations in young onset pancreatic cancer. Cancer Res. 63, 2585\u20132588 (2003).","journal-title":"Cancer Res."},{"key":"BFnrgastro2012111_CR76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/0008-5472.383.65.2","volume":"65","author":"FJ Couch","year":"2005","unstructured":"Couch, F. J. et al. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res. 65, 383\u2013386 (2005).","journal-title":"Cancer Res."},{"key":"BFnrgastro2012111_CR77","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"NJ Roberts","year":"2012","unstructured":"Roberts, N. J. et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2, 41\u201346 (2012).","journal-title":"Cancer Discov."},{"key":"BFnrgastro2012111_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1897-4287-3-3-115","volume":"3","author":"JE Axilbund","year":"2005","unstructured":"Axilbund, J. E. et al. Patient perspective on the value of genetic counselling for familial pancreas cancer. Hered. Cancer Clin. Pract. 3, 115\u2013122 (2005).","journal-title":"Hered. Cancer Clin. Pract."},{"key":"BFnrgastro2012111_CR79","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1200\/JCO.2006.09.2452","volume":"25","author":"W Wang","year":"2007","unstructured":"Wang, W. et al. PancPRO: risk assessment in individuals with a family history of pancreatic cancer. J. Clin. Oncol. 25, 1417\u20131422 (2007).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2012111_CR80","doi-asserted-by":"publisher","unstructured":"Leonardi, M. et al. \u201cPancPro\u201d as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases. Dig. Liver Dis. http:\/\/dx.doi.org\/10.1016\/j.dld.2011.12.019 .","DOI":"10.1016\/j.dld.2011.12.019"},{"key":"BFnrgastro2012111_CR81","first-page":"853","volume":"28","author":"ME Robson","year":"2003","unstructured":"Robson, M. E. et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J. Clin. Oncol. 28, 853\u2013901 (2003).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2012111_CR82","doi-asserted-by":"crossref","unstructured":"Canto, M. I. et al. International consensus recommendations on the management of patients with increased risk for familial pancreatic cancer (Cancer of the Pancreas Screening Consortium [CAPS] 2011 Summit). Presented on behalf of the International CAPS Consortium at Digestive Disease Week 2012.","DOI":"10.1016\/S0016-5085(12)60511-3"},{"key":"BFnrgastro2012111_CR83","first-page":"128","volume":"11","author":"S Bussom","year":"2010","unstructured":"Bussom, S. & Saif, M. W. Methods and rationale for the early detection of pancreatic cancer. Highlights from the \u201c2010 ASCO Gastrointestinal Cancers Symposium\u201d. JOP 11, 128\u2013130 (2010).","journal-title":"JOP"},{"key":"BFnrgastro2012111_CR84","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-131-4-199908170-00003","volume":"131","author":"TA Brentnall","year":"1999","unstructured":"Brentnall, T. A. et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann. Intern. Med. 131, 247\u2013255 (1999).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2012111_CR85","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/S0016-5107(02)70092-8","volume":"56","author":"MB Kimmey","year":"2002","unstructured":"Kimmey, M. B. et al. Screening and surveillance for hereditary pancreatic cancer. Gastrointest. Endosc. 56, S82\u2013S86 (2002).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2012111_CR86","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1542-3565(04)00244-7","volume":"2","author":"MI Canto","year":"2004","unstructured":"Canto, M. I. et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin. Gastroenterol. Hepatol. 2, 606\u2013621 (2004).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2012111_CR87","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.cgh.2006.02.005","volume":"4","author":"MI Canto","year":"2006","unstructured":"Canto, M. I. et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin. Gastroenterol. Hepatol. 4, 766\u2013781 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2012111_CR88","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/ajg.2009.276","volume":"104","author":"JW Poley","year":"2009","unstructured":"Poley, J. W. et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am. J. Gastroenterol. 104, 2175\u20132181 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2012111_CR89","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/gut.2008.171611","volume":"58","author":"P Langer","year":"2009","unstructured":"Langer, P. et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 58, 1410\u20131418 (2009).","journal-title":"Gut"},{"key":"BFnrgastro2012111_CR90","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1158\/1078-0432.CCR-09-3209","volume":"16","author":"EC Verna","year":"2010","unstructured":"Verna, E. C. et al. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin. Cancer Res. 16, 5028\u20135037 (2010).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2012111_CR91","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.gastro.2012.01.005","volume":"142","author":"MI Canto","year":"2012","unstructured":"Canto, M. I. et al. American Cancer of the Pancreas Screening (CAPS) Consortium. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142, 796\u2013804 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2012111_CR92","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1159\/000055851","volume":"1","author":"SJ Rulyak","year":"2001","unstructured":"Rulyak, S. J. et al. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 1, 477\u2013485 (2001).","journal-title":"Pancreatology"},{"key":"BFnrgastro2012111_CR93","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S1091-255X(02)00150-6","volume":"7","author":"CP Raut","year":"2003","unstructured":"Raut, C. P. et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J. Gastrointest. Surg. 7, 118\u2013126 (2003).","journal-title":"J. Gastrointest. Surg."},{"key":"BFnrgastro2012111_CR94","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/ajg.2011.65","volume":"106","author":"E Ludwig","year":"2011","unstructured":"Ludwig, E. et al. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am. J. Gastroenterol. 106, 946\u2013954 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2012111_CR95","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11605-011-1781-6","volume":"30","author":"W Al-Sukhni","year":"2012","unstructured":"Al-Sukhni, W. et al. Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. J. Gastrointest. Surg. 30, 771\u2013783 (2012).","journal-title":"J. Gastrointest. Surg."},{"key":"BFnrgastro2012111_CR96","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2010.11.048","volume":"140","author":"HF Vasen","year":"2011","unstructured":"Vasen, H. F. et al. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 140, 850\u2013856 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2012111_CR97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1399-0012.2004.00110.x","volume":"18","author":"KP Charpentier","year":"2004","unstructured":"Charpentier, K. P., Brentnall, T. A., Bronner, M. P., Byrd, D. & Marsh, C. A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clin. Transplant. 18, 105\u2013107 (2004).","journal-title":"Clin. Transplant."},{"key":"BFnrgastro2012111_CR98","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF01665079","volume":"2","author":"DE Sutherland","year":"1977","unstructured":"Sutherland, D. E., Matas, A. J. & Najarian, J. S. Pancreas and islet transplantation. World J. Surg. 2, 185 (1977).","journal-title":"World J. Surg."},{"key":"BFnrgastro2012111_CR99","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/GIM.0b013e31822934f5","volume":"13","author":"F Harinck","year":"2011","unstructured":"Harinck, F. et al. Feasibility of a pancreatic cancer surveillance program from a psychological point of view. Genet. Med. 13, 1015\u20131024 (2011).","journal-title":"Genet. Med."},{"key":"BFnrgastro2012111_CR100","doi-asserted-by":"publisher","unstructured":"Hart, S. L. et al. Moderators of cancer related distress and worry after a pancreatic cancer genetic counselling and screening intervention. Psychooncology http:\/\/dx.doi.org\/10.1002\/pon.2026 .","DOI":"10.1002\/pon.2026"},{"key":"BFnrgastro2012111_CR101","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10689-010-9354-5","volume":"9","author":"C Maheu","year":"2010","unstructured":"Maheu, C. et al. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam. Cancer 9, 617\u2013624 (2010).","journal-title":"Fam. Cancer"},{"key":"BFnrgastro2012111_CR102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1067\/mge.2003.28","volume":"57","author":"SJ Rulyak","year":"2003","unstructured":"Rulyak, S. J., Kimmey, M. B., Veenstra, D. L. & Brentnall, T. A. Cost\u2013effectiveness of pancreatic cancer screening in familial pancreatic cancer kinderds. Gastrointest. Endosc. 57, 23\u201329 (2003).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2012111_CR103","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000108969","volume":"7","author":"JH Rubenstein","year":"2007","unstructured":"Rubenstein, J. H., Scheimann, J. M. & Anderson, M. A. A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma. Pancreatology 7, 514\u2013525 (2007).","journal-title":"Pancreatology"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2012.111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2012.111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2012.111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T02:48:55Z","timestamp":1687488535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2012.111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,5]]},"references-count":103,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFnrgastro2012111"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2012.111","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,5]]}}}